Abstract: System for better service reselection when on other than the Most Preferred system. In various aspects, methods and corresponding apparatus are provided for a service reselection system that operates on a device to provide better service reselection during idle mode, origination mode and active traffic mode. A method includes detecting entry into slotted mode operation on a Less Preferred system, waiting for page monitoring to complete at selected slot cycle wakeup times, performing a service reselection scan at the selected slot cycle wakeup times to find More Preferred systems, wherein the service reselection scan is performed after the page monitoring has completed, and limiting a time duration of the service reselection scan so as to avoid interference with the page monitoring to be performed at slot cycle wakeup times that follow the selected slot cycle wakeup times.

Abstract: An actuator includes a cylinder and a piston disposed in the cylinder. The piston has a head and a rod. The actuator further includes a collapsible locking member disposed in the head of the piston, and a gas-filled capsule disposed in the cylinder. The gas-filled capsule is in an expanded position when fluid in the cylinder is below a threshold pressure, and the gas-filled capsule is in a collapsed position when fluid in the cylinder is above the threshold pressure. The actuator also includes a lock piston operably connected to the gas-filled capsule. The lock piston engages the collapsible locking member and biases the collapsible locking member radially outward to a locked position when the gas-filled capsule is in the expanded position.

Abstract: There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed. There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.

Abstract: There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed. There is provided a method for treating or reducing the effects of fructose intolerance and health problems associated with excessive fructose intake by administration of glucose isomerase. Other embodiments are also disclosed.

Abstract: There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed.

Abstract: There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed.

Abstract: There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed.

Abstract: The invention provides a composition for use in therapy of lactose intolerance or conditions arising from lactase deficiency, wherein the composition is a non-dairy solid dosage form comprising: (a) a lactase; and (b) one or more lactase-producing and/or lactase containing microorganisms selected from Lactobacillus delbrueckii ssp bulgaricus and Steptococcus thermophilus; wherein the lactase (a) is other than a lactase derived from the said one or more microorganisms (b); and wherein the one or more lactase-producing and/or lactase-containing microorganisms (b) are in dried form. Also provided are uncoated capsule and tablet compositions containing the lactase and the lactase-producing and/or lactase-containing microorganisms.

Abstract: System for better service reselection when on other than the Most Preferred system. In various aspects, methods and corresponding apparatus are provided for a service reselection system that operates on a device to provide better service reselection during idle mode, origination mode and active traffic mode. A method includes detecting entry into slotted mode operation on a Less Preferred system, waiting for page monitoring to complete at selected slot cycle wakeup times, performing a service reselection scan at the selected slot cycle wakeup times to find More Preferred systems, wherein the service reselection scan is performed after the page monitoring has completed, and limiting a time duration of the service reselection scan so as to avoid interference with the page monitoring to be performed at slot cycle wakeup times that follow the selected slot cycle wakeup times.

Abstract: A method for determining the sequence of a polynucleotide, the method relying on the detection of a conformational change in an enzyme that interacts with and processes along the polynucleotide. The detection of a conformational change may be carried out by measuring changes in a fluorophore bound to the enzyme.

Abstract: The invention encompasses additives for addition to a bodywash, where the additives contain one or more sunscreens, and where a bodywash which contains the additive imparts to the skin an SPF of at least about 2, in some cases at least about 5, or 10, or 15. Also described are methods of making and using the additives.

Abstract: The invention encompasses business methods that include supplying an additive for addition to a bodywash, or a bodywash containing such an additive, and receiving payment for the additive or bodywash, as well as encompassing business methods that include designing, testing, and marketing an additive for addition to a bodywash.

Abstract: An apparatus of the present disclosure has a dental tray cup filled with a silicone elastomer and elastomeric sheeting covering the silicone elastomer in the dental tray cup. A method of the present disclosure comprises the steps of providing a dental tray, filling the dental tray with an elastomeric material, covering the elastomeric material in the dental tray with a sheeting.

Abstract: A method for determining the sequence of a polynucleotide, the method relying on the detection of a conformational change in an enzyme that interacts with and processes along the polynucleotide. The detection of a conformational change may be carried out by measuring changes in a fluorophore bound to the enzyme.

Abstract: A method for creating a custom dental tray is made by filling a dental tray with an elastomer material, obtaining a first impression of a patient's teeth in the elastomer material by pressing the elastomer-filled dental tray against the patient's teeth, heating a polymer sheeting, and placing the heated polymer sheeting over the first impression in the elastomer-filled dental tray. In addition, the custom dental tray is made by obtaining a second impression of the patient's teeth in the polymer sheeting by pressing the elastomer-filled dental tray having the first impression and the heated sheeting over the patient's teeth and removing the polymer sheeting from the elastomer-filled dental tray.

Abstract: The present invention pertains to a method for determining the sequence of a polynucleotide, the method relying on the detection of a conformational change in an enzyme that interacts with and processes along the polynucleotide. The detection of a conformational change may be carried out by measuring changes in a fluorophore bound to the enzyme.

Abstract: The present invention relates to a method for determining the sequence of a polynucleotide, the method comprising the steps of: (i) reacting a target polynucleotide with a polymerase enzyme immobilised on a solid support, and the different nucleotides, under conditions sufficient for the polymerase reaction; and (ii) detecting the incorporation of a specific nucleotide complementary to the target polynucleotide, by measuring radiation.

Abstract: Polyester blends comprising (1) polyesters prepared from terephthalic acid, 100 to 5 mol % of 2,2,4,4-tetramethyl-1,3-cyclobutanediol, and 0 to 95 mol % 1,4-cyclohexanedimethanol and (b) polyesters prepared from terephthalic acid and alkylene glycol. The blends may also contain an impact modifier and a phosphorous stabilizer. These blends can have a combination of thermal stability and toughness—making the materials useful in engineering molding plastics, packaging, films, and fibers.

Abstract: Polymer compositions are disclosed that are blends of polyesters prepared from terephthalic acid, 2,2,4,4-tetramethyl-1,3-cyclobutanediol, and optionally 1,4-cyclohexanedimethanol, with a reinforcing mineral filler. The composition of the blend includes up to about 40 weight % of the mineral. These formulations have a combination of toughness, heat resistance, and high modulus making the materials particularly useful in engineering molding plastics.